Arkolith/Insider Trading/APEN/Form 4

McKhann Chas

President and CEO, DirectorApollo Endosurgery, Inc. (APEN) · full profile →Form 4 · filed Apr 4, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
1 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 4, 2023Disposed to issuer(D)690K——0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 4, 2023Disposed to issuer(D)849K——0
Apr 4, 2023Disposed to issuer(D)459K——0

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001251769-23-000027) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML